132 related articles for article (PubMed ID: 33786913)
21. Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site.
Eizert H; Bander P; Bagossi P; Sperka T; Miklóssy G; Boross P; Weber IT; Tözsér J
J Virol; 2008 Oct; 82(20):10111-7. PubMed ID: 18701588
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of XMRV and HIV-1 proteases by pepstatin A and acetyl-pepstatin.
Matúz K; Mótyán J; Li M; Wlodawer A; Tőzsér J
FEBS J; 2012 Sep; 279(17):3276-86. PubMed ID: 22804908
[TBL] [Abstract][Full Text] [Related]
23. Effect of dimerizing domains and basic residues on in vitro and in vivo assembly of Mason-Pfizer monkey virus and human immunodeficiency virus.
Bohmová K; Hadravová R; Stokrová J; Tuma R; Ruml T; Pichová I; Rumlová M
J Virol; 2010 Feb; 84(4):1977-88. PubMed ID: 20007269
[TBL] [Abstract][Full Text] [Related]
24. Interaction Interface of Mason-Pfizer Monkey Virus Matrix and Envelope Proteins.
Prchal J; Sýs J; Junková P; Lipov J; Ruml T
J Virol; 2020 Sep; 94(20):. PubMed ID: 32796061
[TBL] [Abstract][Full Text] [Related]
25. The role of the S-S bridge in retroviral protease function and virion maturation.
Zábranská H; Tůma R; Kluh I; Svatos A; Ruml T; Hrabal R; Pichová I
J Mol Biol; 2007 Feb; 365(5):1493-504. PubMed ID: 17140600
[TBL] [Abstract][Full Text] [Related]
26. Conserved cysteines in Mason-Pfizer monkey virus capsid protein are essential for infectious mature particle formation.
Píchalová R; Füzik T; Vokatá B; Rumlová M; Llano M; Dostálková A; Křížová I; Ruml T; Ulbrich P
Virology; 2018 Aug; 521():108-117. PubMed ID: 29906704
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis.
Strambio-de-Castillia C; Hunter E
J Virol; 1992 Dec; 66(12):7021-32. PubMed ID: 1279197
[TBL] [Abstract][Full Text] [Related]
28. Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease.
Li M; Gustchina A; Matúz K; Tözsér J; Namwong S; Goldfarb NE; Dunn BM; Wlodawer A
FEBS J; 2011 Nov; 278(22):4413-24. PubMed ID: 21951660
[TBL] [Abstract][Full Text] [Related]
29. The Mason-Pfizer monkey virus internal scaffold domain enables in vitro assembly of human immunodeficiency virus type 1 Gag.
Sakalian M; Dittmer SS; Gandy AD; Rapp ND; Zábranský A; Hunter E
J Virol; 2002 Nov; 76(21):10811-20. PubMed ID: 12368324
[TBL] [Abstract][Full Text] [Related]
30. Specific in vitro cleavage of Mason-Pfizer monkey virus capsid protein: evidence for a potential role of retroviral protease in early stages of infection.
Rumlová M; Ruml T; Pohl J; Pichová I
Virology; 2003 Jun; 310(2):310-8. PubMed ID: 12781718
[TBL] [Abstract][Full Text] [Related]
31. A tyrosine motif in the cytoplasmic domain of mason-pfizer monkey virus is essential for the incorporation of glycoprotein into virions.
Song C; Dubay SR; Hunter E
J Virol; 2003 May; 77(9):5192-200. PubMed ID: 12692221
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer-associated protein--a novel binding partner of Mason-Pfizer monkey virus protease.
Rumlová M; Křížová I; Hadravová R; Doležal M; Strohalmová K; Keprová A; Pichová I; Ruml T
J Gen Virol; 2014 Jun; 95(Pt 6):1383-1389. PubMed ID: 24659101
[TBL] [Abstract][Full Text] [Related]
33. A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein.
Brody BA; Rhee SS; Sommerfelt MA; Hunter E
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3443-7. PubMed ID: 1565636
[TBL] [Abstract][Full Text] [Related]
34. Cleavage of vimentin by different retroviral proteases.
Snásel J; Shoeman R; Horejsí M; Hrusková-Heidingsfeldová O; Sedlácek J; Ruml T; Pichová I
Arch Biochem Biophys; 2000 May; 377(2):241-5. PubMed ID: 10845700
[TBL] [Abstract][Full Text] [Related]
35. Activity of the Mason-Pfizer monkey virus fusion protein is modulated by single amino acids in the cytoplasmic tail.
Song C; Micoli K; Hunter E
J Virol; 2005 Sep; 79(18):11569-79. PubMed ID: 16140734
[TBL] [Abstract][Full Text] [Related]
36. Membrane Interactions of the Mason-Pfizer Monkey Virus Matrix Protein and Its Budding Deficient Mutants.
Kroupa T; Langerová H; Doležal M; Prchal J; Spiwok V; Hunter E; Rumlová M; Hrabal R; Ruml T
J Mol Biol; 2016 Nov; 428(23):4708-4722. PubMed ID: 27725181
[TBL] [Abstract][Full Text] [Related]
37. Flexible segments modulate co-folding of dUTPase and nucleocapsid proteins.
Németh-Pongrácz V; Barabás O; Fuxreiter M; Simon I; Pichová I; Rumlová M; Zábranská H; Svergun D; Petoukhov M; Harmat V; Klement E; Hunyadi-Gulyás E; Medzihradszky KF; Kónya E; Vértessy BG
Nucleic Acids Res; 2007; 35(2):495-505. PubMed ID: 17169987
[TBL] [Abstract][Full Text] [Related]
38. Internet-based crowdsourcing and research ethics: the case for IRB review.
Graber MA; Graber A
J Med Ethics; 2013 Feb; 39(2):115-8. PubMed ID: 23204319
[TBL] [Abstract][Full Text] [Related]
39. Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3.
Heaslet H; Lin YC; Tam K; Torbett BE; Elder JH; Stout CD
Retrovirology; 2007 Jan; 4():1. PubMed ID: 17212810
[TBL] [Abstract][Full Text] [Related]
40. The impact of altered polyprotein ratios on the assembly and infectivity of Mason-Pfizer monkey virus.
Kohoutová Z; Rumlová M; Andreánsky M; Sakalian M; Hunter E; Pichová I; Ruml T
Virology; 2009 Feb; 384(1):59-68. PubMed ID: 19062065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
